Last week was a tough week for cannabis stocks as ETFs plummeted with disappointing earnings reports. The ETFMG Alternative Harvest ETF MJ, the AdvisorShares Pure Cannabis ETF YOLO, The Cannabis ETF THCX, the Amplify Seymour Cannabis ETF CNBS all lost around 6% on average. Even the SPDR S&P 500 ETF Trust SPY was down 0.4%. The major disappointment was delivered by Aurora Cannabis Inc. ACB's beyond disappointing fourth-quarter earnings report.
What happened with Aurora?
The Edmonton, Canada-based company reported a loss of $2.5 billion for the fiscal year. Total net revenue of $54.1 million dropped 5% from the previous quarter. More specifically, revenue for consumer cannabis in the recreational market dropped 9% to $26.7 million. Revenue for medical cannabis only increased 4% as net revenue was $24.2 million, helped by market growth in Canada and Europe. Continuing operations resulted in a loss of $1.40 billion. The shares plummeted following the results, already being down 91% over the past 12 months, reducing the company's market value to a fraction of its former size.
Departure of Peltz
The past year has been a tough one for Aurora and it doesn't seem to be getting any easier as on Monday, the billionaire investor Nelson Peltz resigned as advisor. Aurora brought in Peltz after Canadian competitors Canopy Growth CGC and Cronos Group CRON locked up multibillion-dollar investments from global liquor giant Constellation Brands STZ and Virginia-based Altria MO, hoping that he will strike a similar deal with his connections to major U.S. consumer goods firms like PepsiCo PEP and Mondelez International MDLZ. Being a director of fast-food holding firm Wendy's Co. WEN and Procter & Gamble PG, he seemed like the perfect person to help the company expand internationally. It was a good idea, but Aurora ended up losing more than $2.6 billion since Peltz joined last year as it failed to catch up to its competitors.
This article is not a press release and is contributed by a verified independent journalist for IAMNewswire. It should not be construed as investment advice at any time please read the full disclosure . IAM Newswire does not hold any position in the mentioned companies. Press Releases – If you are looking for full Press release distribution contact: press@iamnewswire.com Contributors – IAM Newswire accepts pitches. If you're interested in becoming an IAM journalist contact: contributors@iamnewswire.com
The post Cannabis Industry News appeared first on IAM Newswire.
Edge Rankings
Price Trend
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving—don’t get left behind!
Curious about what’s next for the industry and how to stay ahead in today’s competitive market?
Join top executives, investors, and industry leaders at the Benzinga Cannabis Capital Conference in Chicago on June 9-10. Dive deep into market-shaping strategies, investment trends, and brand-building insights that will define the future of cannabis.
Secure your spot now before prices go up—this is where the biggest deals and connections happen!